IL28B Gene Polymorphism SNP rs8099917 Genotype GG Is Associated with HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP) in HTLV-1 Carriers
暂无分享,去创建一个
J. Pinho | O. Luiz | A. Duarte | T. Assone | L. Fonseca | J. Casseb | F. Malta | F. T. Gonçalves | A. C. D. de Oliveira | K. Gaester | Fernando Vieira de Souza | L. A. Fonseca | Tatiane Assone
[1] E. Rondinelli,et al. Interleukin 28B-related polymorphisms: a pathway for understanding hepatitis C virus infection? , 2013, World journal of gastroenterology.
[2] E. Sabino,et al. Lack of evidence to support the association of a single IL28B genotype SNP rs12979860 with the HTLV-1 clinical outcomes and proviral load , 2012, BMC Infectious Diseases.
[3] A. Gessain,et al. Epidemiological Aspects and World Distribution of HTLV-1 Infection , 2012, Front. Microbio..
[4] V. Soriano,et al. Development of tropical spastic paraparesis in human T-lymphotropic virus type 1 carriers is influenced by interleukin 28B gene polymorphisms. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[5] H. Hoshino. Cellular Factors Involved in HTLV-1 Entry and Pathogenicit , 2012, Front. Microbio..
[6] Yasuaki Yamada,et al. Paradoxical expression of IL-28B mRNA in peripheral blood in human T-cell leukemia virus Type-1 mono-infection and co-infection with hepatitis C Virus , 2012, Virology Journal.
[7] J. Pinho,et al. IL28B polymorphisms are markers of therapy response and are influenced by genetic ancestry in chronic hepatitis C patients from an admixed population , 2011, Liver international : official journal of the International Association for the Study of the Liver.
[8] P. Ferenci,et al. Early virologic response and IL28B polymorphisms in patients with chronic hepatitis C genotype 3 treated with peginterferon alfa-2a and ribavirin. , 2011, Journal of hepatology.
[9] C. Thio,et al. IL28B and the control of hepatitis C virus infection. , 2010, Gastroenterology.
[10] J. Goedert,et al. IL28B polymorphism does not determine outcomes of hepatitis B virus or HIV infection. , 2010, The Journal of infectious diseases.
[11] Sven Bergmann,et al. Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study. , 2010, Gastroenterology.
[12] C. Thio,et al. Interleukin-28b: a key piece of the hepatitis C virus recovery puzzle. , 2010, Gastroenterology.
[13] Limin Chen,et al. ISG15, a ubiquitin-like interferon-stimulated gene, promotes hepatitis C virus production in vitro: implications for chronic infection and response to treatment. , 2010, The Journal of general virology.
[14] A. Duarte,et al. The Elevated Interferon Gamma Production is an Important Immunological Marker in HAM/TSP Pathogenesis , 2009, Scandinavian journal of immunology.
[15] Thomas Berg,et al. IL28B is associated with response to chronic hepatitis C interferon-α and ribavirin therapy , 2009, Nature Genetics.
[16] Jacques Fellay,et al. Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance , 2009, Nature.
[17] Tom R. Gaunt,et al. American Journal of Epidemiology Practice of Epidemiology Hardy-weinberg Equilibrium Testing of Biological Ascertainment for Mendelian Randomization Studies , 2022 .
[18] A. Duarte,et al. High production of RANTES and MIP-1α in the tropical spastic paraparesis/HTLV-1-associated myelopathy (TSP/HAM) , 2007, Journal of Neuroimmunology.
[19] G. Gallagher,et al. Human interferon lambda-1 (IFN-lambda1/IL-29) modulates the Th1/Th2 response. , 2007, Genes and immunity.
[20] G. Gallagher,et al. Human interferon lambda-1 (IFN-λ1/IL-29) modulates the Th1/Th2 response , 2007, Genes and Immunity.
[21] Inês Dourado,et al. Perfil sociodemográfico, epidemiológico e comportamental de mulheres infectadas pelo HTLV-1 em Salvador-Bahia, uma área endêmica para o HTLV , 2007 .
[22] I. Dourado,et al. [Sociodemographic, epidemiological and behavioral profile of women infected with HTLV-1 in Salvador, Bahia, an endemic area for HTLV]. , 2007, Revista da Sociedade Brasileira de Medicina Tropical.
[23] F. Proietti,et al. Immunologic markers, uveitis, and keratoconjunctivitis sicca associated with human T-cell lymphotropic virus type 1. , 2006, American journal of ophthalmology.
[24] P. Marchiori,et al. Human T-cell lymphotropic virus type I (HTLV-I) proviral DNA viral load among asymptomatic patients and patients with HTLV-I-associated myelopathy/tropical spastic paraparesis. , 2005, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.
[25] A. Lézin,et al. Quantitation of HTLV-I proviral load by a TaqMan real-time PCR assay. , 2002, Journal of virological methods.
[26] A. Lloyd,et al. The Influence of HLA Class I Alleles and Heterozygosity on the Outcome of Human T Cell Lymphotropic Virus Type I Infection1 , 2000, The Journal of Immunology.
[27] R. Edlich,et al. Global epidemic of human T-cell lymphotropic virus type-I (HTLV-I). , 2000, The Journal of emergency medicine.
[28] J. Dipierri,et al. Characteristic distribution of HTLV type I and HTLV type II carriers among native ethnic groups in South America. , 1999, AIDS research and human retroviruses.
[29] S. Izumo,et al. Analysis of HTLV-I proviral load in 202 HAM/TSP patients and 243 asymptomatic HTLV-I carriers: high proviral load strongly predisposes to HAM/TSP. , 1999, Journal of neurovirology.
[30] M. Levin,et al. Immunopathogenesis of HTLV-I associated neurologic disease: massive latent HTLV-I infection in bone marrow of HAM/TSP patients. , 1997, Leukemia.
[31] G. Burgess,et al. Cyclic AMP negatively controls c-myc transcription and G1 cell cycle progression in p210 BCR-ABL transformed cells: inhibitory activity exerted through cyclin D1 and cdk4 , 1997, Leukemia.
[32] H. Towler,et al. Adult T-cell leukemia : antigen in an ATL cell line and detection of antibodies to the antigen in human sera , 2022 .